Skip to main content

13 October 2026

Last updated: Tuesday 13 October 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The promise of episomal reprogramming

Sunday 24 November 2013

Interviewee/Contributor

Nick Seay

Organisation

Cellular Dynamics International Inc

Organisations

Marks and Clerk Solicitors LLP
VaxEquity Ltd
Sen-Jam Pharmaceutical
TiGenix NV
Independent regulatory affairs professional
Adrenomed AG
European Biopharmaceutical Enterprises
MedNous editorial board member
Index Ventures
Novo Nordisk Biotech Fund

Interviewees and Contributers

Dr Jochen Klupp
Dario Neri
Glenn Crocker
Vincenzo Salvatore
Keith Blundy
Peter Charlish
André Choulika
Johan Strömquist and Thomas Lönngren
Greg Mullen
Ravi Nalliah

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Bavarian Nordic appoints new CEO

Monday 12 October 2026

Leadership transition at Nuclera

Monday 12 October 2026

HMNC insider named CEO

Monday 12 October 2026

Snycona Investment Management makes leadership changes

Monday 12 October 2026

Hansa Biopharma adds directors to board

Monday 12 October 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form